Heron Therapeutics, Inc.
HRTXDrugs in Pipeline
17
Phase 3 Programs
6
Upcoming Catalysts
1
Next Catalyst
This month
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
B10 L-BPA Injection Phase 2 Est. Readout
Primary completion for B10 L-BPA Injection trial (NCT06668987) in Meningioma
SourceBupivacaine HCl
Postoperative Pain
HTX-011
Postoperative Pain
Ondansetron
Chemotherapy-induced Nausea and Vomiting
APF530
Nausea and Vomiting
Ibuprofen
Analgesia
Celecoxib
Analgesia
aprepitant
Postoperative Pain
Bupivacaine HCI without epinephrine
Post-Operative Pain
Ketorolac
Postoperative Pain
HTX-011B
Postoperative Pain
Acetaminophen
Analgesia
B10 L-BPA Injection
Meningioma
HTX-011A
Postoperative Pain
Bupivacaine HCl without epinephrine
Postoperative Pain
Bupivicaine HCl
Postoperative Pain
HTX-034
Bunions
Bupivacaine HCI (Marcaine)
Postoperative Pain
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Bupivacaine HCl | Phase 3 | Postoperative Pain | - | - |
HTX-011 | Phase 3 | Postoperative Pain | - | - |
Ondansetron | Phase 3 | Chemotherapy-induced Nausea and Vomiting | - | - |
APF530 | Phase 3 | Nausea and Vomiting | - | - |
Ibuprofen | Phase 3 | Analgesia | - | - |
Celecoxib | Phase 3 | Analgesia | - | - |
aprepitant | Phase 2 | Postoperative Pain | - | - |
Bupivacaine HCI without epinephrine | Phase 2 | Post-Operative Pain | - | - |
Ketorolac | Phase 2 | Postoperative Pain | - | - |
HTX-011B | Phase 2 | Postoperative Pain | - | - |
Acetaminophen | Phase 2 | Analgesia | - | - |
B10 L-BPA Injection | Phase 2 | Meningioma | - | - |
HTX-011A | Phase 2 | Postoperative Pain | - | - |
Bupivacaine HCl without epinephrine | Phase 2 | Postoperative Pain | - | - |
Bupivicaine HCl | Phase 2 | Postoperative Pain | - | - |
HTX-034 | Phase 2 | Bunions | - | - |
Bupivacaine HCI (Marcaine) | Phase 2 | Postoperative Pain | - | - |